Scientific Online Resource System

Scripta Scientifica Medica


A. Belcheva, V. Lozeva, K. Marazova


The aim of the present study was to analyze and compare the consumption of psychotropic drugs in the Varna district and in Bulgaria during the period 1985-1990 and to obtain data to be used for the marketing and planning of psychotropic drugs utilization in the new situation of free market and trading. The utilization of tranquilizers, neuroleptics, antidepressants, lithium salts, nootropic drugs and phenylethylamine psychostimulants was studied. The measurement of drug consumption was based on the total sales data obtained from the Bulgarian National Organization for Drug Supply. The unit of measurement were the Defined Daily Doses /1000 inhabitants/ day. The total consumption of psychotropic drugs both in the Varna district and in Bulgaria was 22 DDD/ 1000 inhabitants/ day in 1985 and increased by about 35 % during the period under study. The proportional share among the different drug groups in the Varna district was similar to that in Bulgaria. Benzodiazepine tranquilizers were the most used psychotropic drugs, followed by nootropic drugs, antidepressants and neuroleptics. The total consumption in Bulgaria shows certain similarities with other European countries in the profile and the trends but differs significantly in DDD values.


Psychotropic drugs; consumption; Defined Daily Doses; Varna district; Bulgaria

Full Text


Barnas, C., W. W. Fl is hh , . Stuppack. Pharmacopsychiatry, 21, 1988, 270-271.

Bellantuonno, C., R. Fiorio, P. Williams, E. Arreghini et al. Eur. Arch. Psychiat. Neurol. Sci., 237, 1988, 347-350.

Вjorndal, A., O. Lingjoerde, P. Fugеlli . - In: Drug Utilization in Norway During the 1970's - Increases, Inequalities, Innovation. Oslo, Aktiotrykkeriet, 1983, 203-217.

Finnish Statistics on Medicines, 1991. Helsinki, The Finnish Committee on Drug Information and Statistics, 1992.

Idanpaan - Heikkilajj. WHO Reg. Publ. Eur. Series, 1979, No 8, 35-49.

Leuschner, U., H. Walter. - In : 14th Symp. Clin. Pharmacol. Berlin, 1-3.VIII.1989, Abstracts, p. 92.

Lunde, P. К. M., I. Baksaas, M. Halse, L. K. Halvorsen et al. WHO Reg. Publ. Eur. Series, 1979, No 8, 17-29.

Miiller-Oerolinghaus, В., L. G. Schmidt. - In: Epidemiological Concepts in Clinical Pharmacology. Berlin, etc., Springer-Verlag, 1987, 125-137.

Nordisk lakemedelsstatistics 1978-1980 Del 2. Nordiskt lakemedelsregister med klassificering och definierade dygnsdoser. Uppsala, NLN Publikation nr 9 Nordic Council on Medicines, 1982.

Ruiz, I., J. Offermanns, P. Fuеntеs, M. Castillo. Eur. J . Clin. Pharmacol, 37, 1989, 139-143.

Wede, O. WHO Reg. Publ. Eur. Series, 1979, No 8, 3-17.

WHO Technical Report Series No 615. Geneva, 1977.

Wisowski, D. K., C. Baum. Arch. Gen. Psychiat., 46, 1989.

Wolf, В., R. Grohman, D. Biber, P. Brenner, et al. Pharmacopsychiatry, 22, 1989, 54-60.

Woods, J. H., J. L. Katz, G. Winger. Pharmacol. Rev., 44, 1992, No 2, 151-347.

Article Tools
Email this article (Login required)
About The Authors

A. Belcheva

V. Lozeva

K. Marazova

Font Size